This position statement by The North American Menopause Society (NAMS) evaluates the efficacy and safety of testosterone therapy in postmenopausal women, particularly for treating hypoactive sexual desire disorder (HSDD). Testosterone therapy has been associated with improvements in sexual desire, arousal, and satisfaction, though potential adverse effects include hirsutism, acne, and
